315 related articles for article (PubMed ID: 16728625)
1. Energy deregulation: licensing tumors to grow.
Garber K
Science; 2006 May; 312(5777):1158-9. PubMed ID: 16728625
[No Abstract] [Full Text] [Related]
2. The Warburg Effect returns to the cancer stage.
Zhivotovsky B; Orrenius S
Semin Cancer Biol; 2009 Feb; 19(1):1-3. PubMed ID: 19162190
[No Abstract] [Full Text] [Related]
3. Glucose metabolism and cancer.
Shaw RJ
Curr Opin Cell Biol; 2006 Dec; 18(6):598-608. PubMed ID: 17046224
[TBL] [Abstract][Full Text] [Related]
4. Cancer's sweet tooth.
Bui T; Thompson CB
Cancer Cell; 2006 Jun; 9(6):419-20. PubMed ID: 16766260
[TBL] [Abstract][Full Text] [Related]
5. TORward AKTually useful mouse models.
Mellinghoff IK; Sawyers CL
Nat Med; 2004 Jun; 10(6):579-80. PubMed ID: 15170198
[No Abstract] [Full Text] [Related]
6. AKT crystal structure and AKT-specific inhibitors.
Kumar CC; Madison V
Oncogene; 2005 Nov; 24(50):7493-501. PubMed ID: 16288296
[TBL] [Abstract][Full Text] [Related]
7. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
Jiang W; Zhu Z; Thompson HJ
Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
[TBL] [Abstract][Full Text] [Related]
9. Effects of mitochondrial inhibitors on cell viability in U937 monocytes under glucose deprivation.
Han M; Im DS
Arch Pharm Res; 2008 Jun; 31(6):749-57. PubMed ID: 18563357
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
Yalcin A; Telang S; Clem B; Chesney J
Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
[TBL] [Abstract][Full Text] [Related]
11. The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells?
Moreno-Sánchez R; Rodríguez-Enríquez S; Saavedra E; Marín-Hernández A; Gallardo-Pérez JC
Biofactors; 2009; 35(2):209-25. PubMed ID: 19449450
[TBL] [Abstract][Full Text] [Related]
12. Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma.
Geschwind JF; Georgiades CS; Ko YH; Pedersen PL
Expert Rev Anticancer Ther; 2004 Jun; 4(3):449-57. PubMed ID: 15161443
[TBL] [Abstract][Full Text] [Related]
13. Emerging metabolic targets in cancer therapy.
Zhao Y; Liu H; Riker AI; Fodstad O; Ledoux SP; Wilson GL; Tan M
Front Biosci (Landmark Ed); 2011 Jan; 16(5):1844-60. PubMed ID: 21196269
[TBL] [Abstract][Full Text] [Related]
14. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1.
Semenza GL
Biochem J; 2007 Jul; 405(1):1-9. PubMed ID: 17555402
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria in cancer: not just innocent bystanders.
Frezza C; Gottlieb E
Semin Cancer Biol; 2009 Feb; 19(1):4-11. PubMed ID: 19101633
[TBL] [Abstract][Full Text] [Related]
16. Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises.
Yap TA; Garrett MD; Walton MI; Raynaud F; de Bono JS; Workman P
Curr Opin Pharmacol; 2008 Aug; 8(4):393-412. PubMed ID: 18721898
[TBL] [Abstract][Full Text] [Related]
17. ATP citrate lyase inhibitors as novel cancer therapeutic agents.
Zu XY; Zhang QH; Liu JH; Cao RX; Zhong J; Yi GH; Quan ZH; Pizzorno G
Recent Pat Anticancer Drug Discov; 2012 May; 7(2):154-67. PubMed ID: 22339355
[TBL] [Abstract][Full Text] [Related]
18. ATP-citrate lyase: a key player in cancer metabolism.
Zaidi N; Swinnen JV; Smans K
Cancer Res; 2012 Aug; 72(15):3709-14. PubMed ID: 22787121
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria in cancer cells: what is so special about them?
Gogvadze V; Orrenius S; Zhivotovsky B
Trends Cell Biol; 2008 Apr; 18(4):165-73. PubMed ID: 18296052
[TBL] [Abstract][Full Text] [Related]
20. [Drug resistance mediated by survival- and growth-promoting signaling pathways].
Fujita N
Gan To Kagaku Ryoho; 2009 Apr; 36(4):567-71. PubMed ID: 19381028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
